(Q51184992)

1 April 2018

review article

1 reference

title

[Current indications for voriconazole in onco-hematological patients]. (English)

1 reference

1 April 2018

1 reference

Isidro Jarque

1

1 reference

1 April 2018

Miguel A Sanz

series ordinal

2

1 reference

1 April 2018

publication date

1 September 2007

1 reference

1 April 2018

Revista iberoamericana de micologia

published in

1 reference

1 April 2018

volume

24

1 reference

1 April 2018

issue

3

1 reference

1 April 2018

page(s)

213-216

1 reference

1 April 2018

Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Disseminated Pseudallescheria boydii infection successfully treated with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Burden of aspergillosis-related hospitalizations in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Zygomycosis: reemergence of an old pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Invasive aspergillosis in 2002: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successful treatment of Acremonium fungemia with voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Invasive Acremonium strictum infection in a bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

[Changing epidemiological aspects of candidemia and their clinical and therapeutic implications].

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Zygomycete infection following voriconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Successful Voriconazole Therapy of Disseminated Fusarium Solani in the Brain of a Neutropenic Cancer Patient

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970045-1

7 January 2021

10.1016/S1130-1406(07)70045-1

Identifiers

DOI

1 reference

1 April 2018

1 reference

1 April 2018